Lantern Pharma
LTRN
LTRN
23 hedge funds and large institutions have $5.4M invested in Lantern Pharma in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
8
Closed
6
Calls
$43K
Puts
$2K
Net Calls
+$41K
Net Calls Change
+$297K
Top Buyers
1 |
Jane Street
New York
|
$91.4K |
2 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
$73K |
3 |
CM
CM Management
Gulf Breeze,
Florida
|
$362K |
4 |
Citadel Advisors
Miami,
Florida
|
$117K |
5 |
UBS Group
Zurich,
Switzerland
|
$89.6K |